Novacyt S.A. (“Novacyt”, the “Company” or the “Group”): Publication of Annual Report and AGM voting
01 Juni 2022 - 08:00AM
Business Wire
Regulatory News:
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international
specialist in clinical diagnostics, announces that the Company's
Annual Report and Accounts ("Annual Report") for the year ended 31
December 2021 has been published and uploaded to the Company's
website. The Annual Report has been posted to all shareholders that
hold ordinary shares through CREST Depository Interests (CDIs).
The Company’s Annual General Meeting (“AGM”) will be held as an
open online meeting at 1pm BST/2pm CEST on Tuesday, 21 June 2022.
As usual, and in accordance with French corporate law, the AGM
comprises both ordinary and extraordinary general meetings.
The Notice of AGM and a Form of Proxy are available on the
Company’s website, together with AGM registration details and a
video explaining the voting process to shareholders. All materials
can be found at www.novacyt.com/investors.
Shareholders can register for the AGM and access the online
meeting by visiting https://novacyt.eventcaster.co.uk.
Registrations must include an electronic signature and be
accompanied by proof of shareholding by 10.59pm BST/11.59pm CEST on
Thursday 16 June 2022.
Shareholders are strongly encouraged to submit their proxy votes
either by post, email or vote electronically in accordance with the
instructions in the Notice of AGM.
Shareholders can vote in advance of the AGM until 3pm BST/4pm
CEST on Monday 20 June 2022 by:
- Downloading a copy of the Proxy voting form from
www.novacyt.com/investors for completion and return to
investor.relations@novacyt.com together with evidence of their
holding.
- Voting on-line using the AGM portal
https://novacyt.eventcaster.co.uk together with an electronic
signature and proof of shareholding.
- Voting on-line using the Votaccess portal
http://www.actionnaire.cic-marketsolutions.eu if securities held on
Euronext Growth are registered with any of the following banks:
CIC, Natixis, Société Générale, Caceis, Crédit Agricole, BP2S, BNP
Retail, Bourse Direct, ODDO, Rothschild Martin Maurel, Procapital,
Citibank, Deutsche Bank or JP Morgan.
Under French law, for the AGM and EGM meetings to be quorate at
the first attempt, at least 20% of shareholders must vote on the
ordinary resolutions and 25% of shareholders must vote on the
extraordinary resolutions.
Following registration and proof of shareholding, shareholders
will be able to virtually attend the AGM and vote online during the
meeting if they wish. Following the meeting, a recording of the AGM
will be available on the Company’s website at
www.novacyt.com/investors. Shareholders who have already voted
(through a proxy, using the AGM or Votaccess portals) will be
allowed to attend the AGM but will not be able to vote twice.
About Novacyt Group
The Novacyt Group is an international diagnostics business
generating an increasing portfolio of in vitro and molecular
diagnostic tests. Its core strengths lie in diagnostics product
development, commercialisation, contract design and manufacturing.
The Company supplies an extensive range of high-quality assays and
reagents worldwide. The Group directly serves microbiology,
haematology and serology markets as do its global partners, which
include major corporates.
For more information, please refer to the website:
www.novacyt.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220531006027/en/
Novacyt SA David Allmond, Chief Executive Officer James
McCarthy, Chief Financial Officer +44 (0)1276 600081
SP Angel Corporate Finance LLP (Nominated Adviser and
Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470
0470
Numis Securities Limited (Joint Broker) Freddie Barnfield
/ James Black / Duncan Monteith +44 (0)20 7260 1000
Allegra Finance (French Listing Sponsor) Rémi Durgetto /
Yannick Petit +33 (1) 42 22 10 10 r.durgetto@allegrafinance.com;
y.petit@allegrafinance.com
FTI Consulting (International) Victoria Foster Mitchell /
Alex Shaw +44 (0)20 3727 1000
victoria.fostermitchell@fticonsulting.com /
Alex.Shaw@fticonsulting.com
FTI Consulting (France) Arnaud de Cheffontaines +33
(0)147 03 69 48 arnaud.decheffontaines@fticonsulting.com
Novacyt (EU:ALNOV)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Novacyt (EU:ALNOV)
Historical Stock Chart
Von Mär 2023 bis Mär 2024